Konstantin Adamsky
Director/Board Member at FILAMENT HEALTH CORP.
Profile
Konstantin Adamsky is the founder of Celleska Pty Ltd.
He is currently the Chief Executive Officer at Negev Labs and an Independent Director at Filament Health Corp.
Previously, he served as the Co-Chief Executive Officer & Director at Targia Pharmaceuticals Ltd.
in 2016.
He also held the position of Vice President-Operations & Technology at Levco Pharmaceuticals Ltd.
Additionally, he worked as the Vice President-Operations at Regenera Pharma Ltd.
from 2017 to 2020.
Dr. Adamsky obtained a doctorate degree from the Weizmann Institute of Science.
Konstantin Adamsky active positions
| Companies | Position | Start |
|---|---|---|
| FILAMENT HEALTH CORP. | Director/Board Member | 23/08/2022 |
Former positions of Konstantin Adamsky
| Companies | Position | End |
|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Chief Executive Officer | 01/08/2017 |
| Levco Pharmaceuticals Ltd. | Chief Operating Officer | - |
Training of Konstantin Adamsky
| Weizmann Institute of Science | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FILAMENT HEALTH CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
| Levco Pharmaceuticals Ltd. |
- Stock Market
- Insiders
- Konstantin Adamsky
